
4.04 Delayed Data As of Jan 22 | ![]() Today’s Change | 0.88 Today|||52-Week Range 9.02 | +13.80% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $343.9M |
Arbutus Biopharma Corp. 701 Veterans Circle Warminster Pennsylvania 18974 |
William H. Collier | President, Chief Executive Officer & Director |
David C. Hastings | Chief Financial & Accounting Officer |
Michael J. Sofia | Chief Scientific Officer |
Elizabeth Howard | Chief Compliance Officer, EVP & General Counsel |
Michael J. McElhaugh | Chief Business Officer |